Immunogenicity and safety of inactivated whole virion Coronavirus vaccine with CpG (VLA2001) in healthy adults aged 18 to 55: a randomised phase 1 /2 clinical trial
bioRxiv (2021) - Comments
doi: 10.1101/2021.08.13.21262021 

Rajeka Lazarus, Christian Taucher, Claire Brown, Irena Corbic, Leon Danon, Katrin Dubischar, Christopher J.A. Duncan, Susanne Eder-Lingelbach, Saul N Faust, Christopher Green, Karishma Gokani, Romana Hochreiter, Johanna Kellett Wright, Dowan Kwon, Alexander Middleditch, Alasdair P.S. Munro, Kush Naker, Florentina Penciu, David Price, Benedicte Querton